Tadesse Birhanu
Overview
Explore the profile of Tadesse Birhanu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
103
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Birhanu T, Debelu T, Muhammed S, Getachew F
Vet Med Int
. 2022 Sep;
2022:4868391.
PMID: 36118595
Sheep have many advantages over large ruminants for most smallholder farmers: lower feed costs, quicker turnover, easy management, and appropriate size at slaughter can be mentioned. They produce in a...
2.
Faye G, Birhanu T, Belete T
Infect Drug Resist
. 2021 Dec;
14:5511-5520.
PMID: 34955645
Background: The emergency of multidrug resistance due to the global burden of infectious diseases and drug misuse leads to an urgent identification of new medicines from medicinal plants. The study...
3.
Hailu D, Benayew M, Liknaw T, Ayenew M, Ayalew A, Ayano B, et al.
Risk Manag Healthc Policy
. 2021 Apr;
14:1299-1310.
PMID: 33790675
Background: Coronavirus disease 19 was observed as a pandemic and caused many community health problems that resulted in Global issues. It causes death for many individuals including health professionals. This...
4.
Geleta T, Deriba B, Beyane R, Mohammed A, Birhanu T, Jemal K
Int J Gen Med
. 2020 Nov;
13:1011-1023.
PMID: 33177864
Background: The Coronavirus Diseases 2019 (COVID-19) causes a unique threat and a great challenge to chronic disease patients. Apart from its severity for all communities, a chronic disease patient is...
5.
Gebru A, Birhanu T, Wendimu E, Ayalew A, Mulat S, Abasimel H, et al.
Hum Antibodies
. 2020 Sep;
29(2):129-137.
PMID: 32865184
Background: The Novel Coronavirus Disease 2019 (COVID-19) has proved to be one of the most burdensome respiratory disease outbreaks ever. Moreover, the public health emergency of the COVID-19 outbreak has...
6.
Gebru A, Birhanu T, Wendimu E, Ayalew A, Mulat S, Abasimel H, et al.
Hum Antibodies
. 2020 Sep;
29(2):149-169.
PMID: 32865183
Background: COVID-19 is currently the major public health burden in the world, with disease and death in the global community from COVID-19 increasing rapidly from time to time worldwide. However,...
7.
Gebru A, Birhanu T, Wendimu E, Ayalew A, Mulat S, Abasimel H, et al.
Hum Antibodies
. 2020 Aug;
29(2):139-148.
PMID: 32804122
Background: The novel Coronavirus Disease 2019 (COVID-19) is the major public health burden in the world. The morbidity and mortality of the global community due to this disease is dramatically...
8.
Ejeta E, Chala M, Arega G, Ayalsew K, Tesfaye L, Birhanu T, et al.
J Infect Dev Ctries
. 2015 Aug;
9(7):752-9.
PMID: 26230126
Introduction: Treatment outcome is an important indicator of tuberculosis control programs, as suggested by the World Health Organization. However, this has not been well documented in the study area. This...